Ivermectin

CAS 70288-86-7 7 current records 2 historicalSmall Molecule

Who holds supplier records for Ivermectin? 7 organisations hold a current record for Ivermectin: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (4), Macau (1) and Italy (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Ivermectin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ivermectin

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in China

    4 of the 6 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Ivermectin expires 13 Mar 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ivermectin. Country is the organisation's recorded country, not necessarily the manufacturing site.

China4Macau1Italy1Country not recorded for 1
  • HOVIONE PHARMASCIENCE LTD
    Active DMF 21395 · latest filing Mar 2008
    MacauCEP
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
    Active DMF 21624 · latest filing May 2008
    ChinaCEP Company GMP cert on record
  • HEBEI MEIHE PHARMACEUTICAL CO LTD
    Active DMF 38553 · latest filing Jun 2023
  • Chemo Biosynthesis s.r.l.
    ItalyCEP Company GMP cert on record
  • HEBEI VEYONG PHARMACEUTICAL CO., LTD.
    ChinaCEP
  • Shandong Qilu King-phar Pharmaceutical Co., Ltd.
    ChinaCEP
  • North China Pharmaceutical Group Aino Co., Ltd.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Ivermectin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Ivermectin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2025-175 - Rev 02
Ivermectin, Code iverm11
Oct 2026—
CHEMO BIOSYNTHESIS S.R.L. CoranaIT
CEP 2021-382 - Rev 00
Ivermectin
Aug 2024Inspected Feb 2026
Italy
HEBEI VEYONG PHARMACEUTICAL CO., LTD. ShijiazhuangCN
R0-CEP 2021-477 - Rev 00
Ivermectin, Process II
Apr 2022—
Hovione PharmaScience Limited TaipaMO
R1-CEP 1998-138 - Rev 05
Ivermectin
Feb 2020—
SHANDONG QILU KING-PHAR PHARMACEUTICAL CO., LTD. PingyinCN
R1-CEP 2001-077 - Rev 01
Ivermectin
Oct 2017—
North China Pharmaceutical Group Aino Co., Ltd. ShijiazhuangCN
R1-CEP 2004-070 - Rev 01
Ivermectin
Aug 2011—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Ivermectin are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • DELTA TECH LTD
    Inactive DMF 17673 · filed Jul 2004
  • SHANGHAI TONGREN PHARMACEUTICAL CO LTD
    Inactive DMF 13037 · filed Jun 1998

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (15 listed products contain Ivermectin). The latest listed patent expires 13 Mar 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Ivermectin is an antiparasitic agent used to treat several parasitic infestations. It works by binding to glutamate-gated chloride channels, causing paralysis and death of the parasite.

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Antiparasitic; Pediculicide

Therapeutic areas

AntiparasiticDermatology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ivermectin?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Ivermectin: HOVIONE PHARMASCIENCE LTD (Macau), Zhejiang Hisun Pharmaceutical Co., Ltd. (China), HEBEI MEIHE PHARMACEUTICAL CO LTD, Chemo Biosynthesis s.r.l. (Italy), HEBEI VEYONG PHARMACEUTICAL CO., LTD. (China), Shandong Qilu King-phar Pharmaceutical Co., Ltd. (China) and North China Pharmaceutical Group Aino Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ivermectin Drug Master Files are active?

HOVIONE PHARMASCIENCE LTD (DMF 21395), Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 21624) and HEBEI MEIHE PHARMACEUTICAL CO LTD (DMF 38553). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ivermectin records mean?

2 organisations have only inactive Type II DMFs for Ivermectin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Ivermectin have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Ivermectin on the EDQM register, including ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou (CN), CHEMO BIOSYNTHESIS S.R.L. Corana (IT), HEBEI VEYONG PHARMACEUTICAL CO., LTD. Shijiazhuang (CN), Hovione PharmaScience Limited Taipa (MO), SHANDONG QILU KING-PHAR PHARMACEUTICAL CO., LTD. Pingyin (CN) and North China Pharmaceutical Group Aino Co., Ltd. Shijiazhuang (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Ivermectin?

Yes. The latest patent listed for an approved US product containing Ivermectin expires 13 Mar 2034, across 15 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Ivermectin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ivermectin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.